The University of Chicago Header Logo

Connection

Ravi Salgia to Programmed Cell Death 1 Receptor

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about Programmed Cell Death 1 Receptor.
Ravi Salgia
Connection Strength
0.572
Programmed Cell Death 1 Receptor
  1. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. J Immunother Cancer. 2018 01 23; 6(1):8.
    View in: PubMed
    Score: 0.572
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.